New guidelines are now out for treating panic disorder

September 1998

New guidelines are now out for treating panic disorder.

They point out advantages and disadvantages of therapy with benzodiazepines...SSRIs...tricyclic antidepressants...and MAOIs.

Benzodiazepines (Xanax, etc) have a fast onset. But they can lead to dependence...and cause withdrawal symptoms when patients try to stop.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether hormone replacement therapy reduces the risk of heart disease
Asthma Singulair (montelukast), the second leukotriene receptor antagonist for asthma
Antidepressants new antidepressant called Celexa (citalopram)
Antidepressants realizing that SSRIs can cause weight GAIN
Ophthalmology eye drop bottles don't last as long as they should
Ophthalmology new warnings about Xalatan and hyperpigmentation
Cardiology recommendations for using Viagra in patients with heart disease
Women's Health estrogen/progestin patch for menopausal symptoms
Women's Health new low-dose oral contraceptive, Levlite, in the U.S.
saw palmetto provides SYMPTOMATIC benefit in men with benign prostatic hyperplasia (BPH)
Diabetes estrogen helps prevent and treat type 2 diabetes in postmenopausal women
Diabetes new warnings of liver dysfunction in patients taking Precose, Prandase (acarbose)
Breast Cancer more women with breast cancer treated with a bisphosphonate
New guidelines are now out for treating panic disorder
Pediatrics it's better to give an IM injection of vitamin K to newborns
Rheumatoid Arthritis two exciting new drugs for rheumatoid arthritis